Familial hypercholesterolemia in children and adolescents: A clinical perspective

Journal of Clinical Lipidology

Volumn 9, Issue 5, 2015, Pages S11-S19

  De Ferranti, Sarah D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Adolescent; Child; Cholesterol; Familial hypercholesterolemia; Prevalence; Screening; Treatment

Indexed keywords

APOLIPOPROTEIN B; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOMITAPIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MIPOMERSEN; POLICOSANOL; PRAVASTATIN; STANOL ESTER; STANOZOLOL; TRIACYLGLYCEROL; XUEZHIKANG;

ADOLESCENT; ANTISENSE THERAPY; APOB GENE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHILD; CHILD CARE; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; GENE; GENETIC SCREENING; HUMAN; ISCHEMIC HEART DISEASE; LDLR GENE; LIFESTYLE MODIFICATION; LIPID ANALYSIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PCSK9 GENE; PHYSICAL EXAMINATION; POINT MUTATION; PREVALENCE; PRIORITY JOURNAL; DIETARY SUPPLEMENT; HOMOZYGOTE; HYPERLIPOPROTEINEMIA TYPE II;

ADOLESCENT; CHILD; DIETARY SUPPLEMENTS; GENETIC TESTING; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II;

EID: 84940933549     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.04.009     Document Type: Review

References (58)

1. M. Benn, G.F. Watts, A. Tybjaerg-Hansen, and B.G. Nordestgaard Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication J Clin Endocrinol Metab 97 11 2012 3956 3964
2. G.F. Watts, S. Gidding, A.S. Wierzbicki, and et al. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation J Clin Lipidol 8 2 2014 148 172
3. J.L. Goldstein, H.G. Schrott, W.R. Hazzard, E.L. Bierman, and A.G. Motulsky Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia J Clin Invest 52 7 1973 1544 1568
4. A. Neil, J. Cooper, J. Betteridge, and et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study Eur Heart J 29 21 2008 2625 2633
5. J. Versmissen, D.M. Oosterveer, M. Yazdanpanah, and et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study BMJ 337 2008 a2423
6. P.N. Hopkins, P.P. Toth, C.M. Ballantyne, and D.J. Rader Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 3 Suppl 2011 S9 S17
7. A.C. Goldberg, P.N. Hopkins, P.P. Toth, and et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 3 Suppl 2011 S1 S8
8. P. Pauciullo, A. Iannuzzi, R. Sartorio, and et al. Increased intima-media thickness of the common carotid artery in hypercholesterolemic children Arterioscler Thromb 14 7 1994 1075 1079
9. S. Tonstad, O. Joakimsen, E. Stensland-Bugge, and et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects Arterioscler Thromb Vasc Biol 16 8 1996 984 991
10. A. Wiegman, E. de Groot, B.A. Hutten, and et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia Lancet 363 9406 2004 369 370
11. D.M. Kusters, A. Wiegman, J.J. Kastelein, and B.A. Hutten Carotid intima-media thickness in children with familial hypercholesterolemia Circ Res 114 2 2014 307 310
12. A. Wiegman, B.A. Hutten, E. de Groot, and et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial JAMA 292 3 2004 331 337
13. J. Rodenburg, M.N. Vissers, A. Wiegman, and et al. Statin treatment in children with familial hypercholesterolemia: the younger, the better Circulation 116 6 2007 664 668
14. D.M. Kusters, H.J. Avis, E. de Groot, and et al. Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia JAMA 312 10 2014 1055 1057
15. M.J. Braamskamp, D.M. Kusters, H.J. Avis, and et al. Patients with familial hypercholesterolemia who initiated statin treatment in childhood are at lower risk for CHD then their affected parents Circulation 128 2013 A17837
16. S. Riggio, G. Mandraffino, M.A. Sardo, and et al. Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children Eur J Clin Invest 40 3 2010 250 257
17. S. de Jongh, M.R. Lilien, J. op't Roodt, E.S. Stroes, H.D. Bakker, and J.J. Kastelein Early statin therapy restores endothelial function in children with familial hypercholesterolemia J Am Coll Cardiol 40 12 2002 2117 2121
18. A.P. Vlahos, K.K. Naka, A. Bechlioulis, and et al. Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia Pediatr Cardiol 35 1 2014 63 70
19. J.L. Goldstein, and M.S. Brown Expression of the familial hypercholesterolemia gene in heterozygotes: model for a dominant disorder in man Trans Assoc Am Physicians 87 1974 120 131
20. R.R. Williams, S.C. Hunt, M.C. Schumacher, and et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics Am J Cardiol 72 2 1993 171 176
21. Familial Hypercholesterolemia (FH): Report of a second WHO consultation 1999 WHO Available at: http://whqlibdoc.who.int/hq/1999/WHO-HGN-FH-CONS-99.2.pdf Accessed April 7, 2015
22. B.G. Nordestgaard, M.J. Chapman, S.E. Humphries, and et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Eur Heart J 34 45 2013 3478 3490a
23. A.C. Goldberg, P.N. Hopkins, P.P. Toth, and et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 3 2011 133 140
24. M.W. Gillman, and S.R. Daniels Is universal pediatric lipid screening justified? JAMA 307 3 2012 259 260
25. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents Pediatrics 89 3 1992 495 501
26. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 19 2001 2486 2497
27. S.R. Daniels, and F.R. Greer Lipid screening and cardiovascular health in childhood Pediatrics 122 1 2008 198 208
28. B.A. Dennison, P.L. Jenkins, and T.A. Pearson Challenges to implementing the current pediatric cholesterol screening guidelines into practice Pediatrics 94 3 1994 296 302
29. J. O'Loughlin, B. Lauzon, G. Paradis, and et al. Usefulness of the American Academy of Pediatrics recommendations for identifying youths with hypercholesterolemia Pediatrics 113 6 2004 1723 1727
30. N. Rifai, E. Neufeld, P. Ahlstrom, E. Rimm, L. D'Angelo, and J.M. Hicks Failure of current guidelines for cholesterol screening in urban African-American adolescents Pediatrics 98 3 Pt 1 1996 383 388
31. S. Shea, C.E. Basch, M. Irigoyen, and et al. Failure of family history to predict high blood cholesterol among Hispanic preschool children Prev Med 19 4 1990 443 455
32. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report Pediatrics 128 Suppl 5 2011 S213 S256
33. M.A. Umans-Eckenhausen, J.C. Defesche, E.J. Sijbrands, R.L. Scheerder, and J.J. Kastelein Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands Lancet 357 9251 2001 165 168
34. Z. Ademi, G.F. Watts, J. Pang, and et al. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia J Clin Lipidol 8 4 2014 390 400
35. P.J. Marang-van de Mheen, A.H. ten Asbroek, L. Bonneux, G.J. Bonsel, and N.S. Klazinga Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands Eur Heart J 23 24 2002 1922 1930
36. J.A. Morrison, C.J. Glueck, and P. Wang The child as proband for future parental cardiometabolic disease: the 26-year prospective Princeton Lipid Research Clinics Follow-up Study J Pediatr 160 4 2012 590 597.e3
37. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group JAMA 273 18 1995 1429 1435
38. H. Niinikoski, H. Lagstrom, E. Jokinen, and et al. Impact of repeated dietary counseling between infancy and 14 years of age on dietary intakes and serum lipids and lipoproteins. The STRIP Study Circulation 116 2007 1032 1040
39. M. Ho, S.P. Garnett, L. Baur, and et al. Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis Pediatrics 130 6 2012 e1647 e1671
40. K. Broekhuizen, M.N. van Poppel, L.L. Koppes, I. Kindt, J. Brug, and W. van Mechelen No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial BMC Res Notes 5 2012 181
41. K. Musa-Veloso, T.H. Poon, J.A. Elliot, and C. Chung A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebo-controlled trials Prostaglandins Leukot Essent Fatty Acids 85 1 2011 9 28
42. Y. Li, L. Jiang, Z. Jia, and et al. A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia PLoS One 9 6 2014 e98611
43. A. Tammi, T. Ronnemaa, H. Gylling, and et al. Plant stanol ester margarine lowers serum total and low-density lipoprotein cholesterol concentrations of healthy children: the STRIP project. Special Turku Coronary Risk Factors Intervention Project J Pediatr 136 4 2000 503 510
44. O. Guardamagna, F. Abello, V. Baracco, B. Stasiowska, and F. Martino The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols Nutr Metab Cardiovasc Dis 21 6 2011 424 429
45. P.O. Kwiterovich Jr. The role of fiber in the treatment of hypercholesterolemia in children and adolescents Pediatrics 96 5 Pt 2 1995 1005 1009
46. B.A. Dennison, and D.M. Levine Randomized, double-blind, placebo-controlled, two-period crossover clinical trial of psyllium fiber in children with hypercholesterolemia J Pediatr 123 1 1993 24 29
47. C. Baigent, A. Keech, P.M. Kearney, and et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 9493 2005 1267 1278
48. Cholesterol Treatment Trialists C C. Baigent, L. Blackwell, J. Emberson, L.E. Holland, C. Reith, and et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 9753 2010 1670 1681
49. A. Vuorio, J. Kuoppala, P.T. Kovanen, and et al. Statins for children with familial hypercholesterolemia Cochrane Database Syst Rev 7 2014 CD006401
50. M.J. Braamskamp, D.M. Kusters, H.J. Avis, and et al. Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence Paediatr Drugs 17 2 2015 159 166
51. S. Tonstad, J. Knudtzon, M. Sivertsen, H. Refsum, and L. Ose Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia J Pediatr 129 1 1996 42 49
52. C.A. Liacouras, P.M. Coates, P.R. Gallagher, and J.A. Cortner Use of cholestyramine in the treatment of children with familial combined hyperlipidemia J Pediatr 122 3 1993 477 482
53. B.W. McCrindle, M.B. O'Neill, G. Cullen-Dean, and E. Helden Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial J Pediatr 130 2 1997 266 273
54. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 25 Pt B 2014 2889 2934
55. J. Besseling, J.J. Kastelein, J.C. Defesche, B.A. Hutten, and G.K. Hovingh Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus JAMA 313 10 2015 1029 1036
56. L.C. Hudgins, B. Kleinman, A. Scheuer, S. White, and B.R. Gordon Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia Am J Cardiol 102 9 2008 1199 1204
57. E. Bruckert Recommendations for the management of patients with homozygous familial hypercholesterolaemia: overview of a new European Atherosclerosis Society consensus statement Atheroscler Suppl 15 2 2014 26 32
58. B. Lefort, S. Saheb, E. Bruckert, C. Giraud, O. Hequet, and R. Hankard Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia Atherosclerosis 239 1 2015 158 162